In accordance with the putative importance of HSP in the pathogenesis of JAK-STAT -related hematological disorders, a recent study described the potential therapeutic use of PU-H71, a HSP90 inhibitor, in experimental models of MPN, ET and PV [13]. The gene discussed is HSP90B2P; the disease is hematologic disorder.